The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria

Table 1 Examples of VIGH research and service initiatives in Nigeria

Study/Grant #	Focus	Years	Fund
1. Renal Risk Reduction ‘R3’ Trial 1U01DK112271 [20]	Chronic kidney disease prevention in HIV	2017–2022	NIDDK
2. SPRING Trial R01NS094041	Primary stroke prevention in sickle cell disease	2015–2020	NINDS
3. BRIDGE Trial R01NS113171	Childhood epilepsy	2019–2024	NINDS/FIC
4. RT-OLA-PCR assays for ARV resistance testing in Nigeria R21AI150828	HIV drug resistance testing in antenatal care	2019–2021	NIAID
5. BRIDGE Trial R21TW010899 [21]	Childhood epilepsy	2017–2019	NINDS/FIC
6. SPRINT Trial TRF1263028 [19]	Secondary stroke prevention in sickle cell disease	2016–2019	Thrasher Foundation
7. Optimizing PMTCT R01HD075075	Implementation science, PMTCT	2012–2016	NICHD/FIC
8. SPIN Trial, R21NS080639 [17, 18]	Primary stroke prevention in sickle cell disease	2012–2015	NINDS
9. FGHiN Nigeria, U2GGH00922	HIV service delivery	2013–2018	CDC/GAP
10. FGH Nigeria U2GPS001063	HIV service delivery	2008–2013	CDC/GAP

ARV antiretrovirals, CDC/GAP Centers for Disease Control and Prevention/Global AIDS Program, FGHiN Friends for Global Health Initiative in Nigeria; FGH Friends in Global Health, FIC Fogarty International Center, SCD sickle cell disease, NIAID National Institute for Allergy and Infectious Diseases, NIDDK National Institute of Diabetes and Digestive and Kidney Diseases, NICHD Eunice Kennedy Shriver National Institute of Child Health and Human Development, NINDS National Institute of Neurological Disorders and Stroke, PMTCT Prevention of mother-to-child HIV transmission

ISSN: 1478-4505